Literature DB >> 20431115

A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.

J Michael Bostwick1.   

Abstract

This review provides a guide to the primary care physician for diagnosing and managing depression. To identify relevant articles, a PubMed search (ending date parameter, October 15, 2009) was conducted using the keywords depression, antidepressants, side effects, adverse effects, weight gain, sexual dysfunction, and sleep disturbance, and the reference lists of relevant articles were hand searched. This review explores the challenges in diagnosing depression that will and will not respond to antidepressants (ADs) and describes the value of 2-question screening instruments followed by in-depth questioning for positive screening results. It underscores the implications of veiled somatic presentations in which underlying depression is missed, leading to fruitless and expensive medical work-ups. Following this survey of the difficulties in diagnosing depression, the 4 options generalists have for treating a patient with depression are discussed: watchful waiting, antidepressant therapy, psychotherapy, and psychiatric referral. This review proposes that physicians, once they decide to prescribe, use AD side effects to advantage by selecting medications to minimize negative and maximize positive possibilities, thereby improving adherence. It focuses on the 3 most troubling adverse effects-sleep disturbance, sexual dysfunction, and weight gain. It provides AD-prescribing principles to assist primary care physicians in successfully managing depression and appropriately referring patients to a psychiatrist. Antidepressant therapy is not a panacea for treating patients with depression. An approach blending enlightened observation, medications, and psychotherapy often helps depressed patients recover to their former baselines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431115      PMCID: PMC2878258          DOI: 10.4065/mcp.2009.0565

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  87 in total

Review 1.  Pharmacogenetics-guided dose modifications of antidepressants.

Authors:  Angela Seeringer; Julia Kirchheiner
Journal:  Clin Lab Med       Date:  2008-12       Impact factor: 1.935

2.  Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.

Authors:  A L Montejo; G Llorca; J A Izquierdo; F Rico-Villademoros
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

3.  15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.

Authors:  Maurizio Fava; A John Rush; Michael E Thase; Anita Clayton; Stephen M Stahl; James F Pradko; J Andrew Johnston
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

4.  Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.

Authors:  Alan D Woolf; Andrew R Erdman; Lewis S Nelson; E Martin Caravati; Daniel J Cobaugh; Lisa L Booze; Paul M Wax; Anthony S Manoguerra; Elizabeth J Scharman; Kent R Olson; Peter A Chyka; Gwenn Christianson; William G Troutman
Journal:  Clin Toxicol (Phila)       Date:  2007       Impact factor: 4.467

5.  Management of ventricular dysrhythmia secondary to trazodone overdose.

Authors:  Kun-Jung Chung; Yu-Chin Lily Wang; Ber-Ming Liu; Robert B Supernaw
Journal:  J Emerg Med       Date:  2007-07-20       Impact factor: 1.484

6.  Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.

Authors:  Rachel Manber; Helena C Kraemer; Bruce A Arnow; Madhukar H Trivedi; A John Rush; Michael E Thase; Barbara O Rothbaum; Daniel N Klein; James H Kocsis; Alan J Gelenberg; Martin E Keller
Journal:  J Consult Clin Psychol       Date:  2008-06

7.  Selective serotonin reuptake inhibitor-induced sexual dysfunction.

Authors:  Giovanni Corona; Valdo Ricca; Elisa Bandini; Edoardo Mannucci; Francesco Lotti; Valentina Boddi; Giulia Rastrelli; Alessandra Sforza; Carlo Faravelli; Gianni Forti; Mario Maggi
Journal:  J Sex Med       Date:  2009-05       Impact factor: 3.802

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 9.  Review: Bupropion and SSRI-induced side effects.

Authors:  K Demyttenaere; L Jaspers
Journal:  J Psychopharmacol       Date:  2008-02-28       Impact factor: 4.153

Review 10.  Escitalopram therapy for major depression and anxiety disorders.

Authors:  David S Baldwin; Elin Heldbo Reines; Christina Guiton; Emmanuelle Weiller
Journal:  Ann Pharmacother       Date:  2007-09-11       Impact factor: 3.154

View more
  12 in total

Review 1.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

2.  Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder.

Authors:  Robert Riesenberg; Joshua Rosenthal; Leslie Moldauer; Christine Peterson
Journal:  Psychopharmacology (Berl)       Date:  2011-12-28       Impact factor: 4.530

Review 3.  Practical suicide-risk management for the busy primary care physician.

Authors:  Anna K McDowell; Timothy W Lineberry; J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2011-06-27       Impact factor: 7.616

4.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

5.  Variations of depression treatment among women with hypertension.

Authors:  Elvonna V Atkins; Usha Sambamoorthi; Rituparna Bhattacharya
Journal:  Health Care Women Int       Date:  2015-01-22

6.  Prescribing ANtiDepressants Appropriately (PANDA): a cluster randomized controlled trial in primary care.

Authors:  Esther Muskens; Rhona Eveleigh; Peter Lucassen; Chris van Weel; Jan Spijker; Peter Verhaak; Anne Speckens; Richard Oude Voshaar
Journal:  BMC Fam Pract       Date:  2013-01-08       Impact factor: 2.497

7.  Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.

Authors:  Fangxi Zhang; Jing Shao; Jingwei Tian; Yan Zhong; Liang Ye; Xiangjing Meng; Qiaofeng Liu; Hongbo Wang
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

8.  Longistyline C acts antidepressant in vivo and neuroprotection in vitro against glutamate-induced cytotoxicity by regulating NMDAR/NR2B-ERK pathway in PC12 cells.

Authors:  Yamin Liu; Ning Zhao; Chenchen Li; Qi Chang; Xinmin Liu; Yonghong Liao; Ruile Pan
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

9.  Antidepressant-like Effect of 3-n-Butylphthalide in Rats Exposed to Chronic Unpredictable Mild Stress: Modulation of Brain-Derived Neurotrophic Factor Level and mTOR Activation in Cortex.

Authors:  Chunlin Chen; Hao Ma; Zhifeng Fu
Journal:  Neurochem Res       Date:  2021-08-10       Impact factor: 3.996

10.  The link between stress disorders and autonomic dysfunction in muscular dystrophy.

Authors:  Rasna Sabharwal
Journal:  Front Physiol       Date:  2014-01-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.